ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury

Recruiting N/A Interventional Study
Spinal Cord Injury SCI SCI - Spinal Cord Injury Subacute Spinal Cord Injury Chronic Spinal Cord Injury Spinal Cord Injury (SCI)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
12 (estimated)
Sponsor
Ecole Polytechnique Fédérale de Lausanne · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The EIGER study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support and promote recovery of ambulatory functions, such as walking, in people with subacute and chronic spinal cord injury.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Must be at least 18 years old and no older than 65 years old at the time of enrollment. 2. Must be graded A, B, C, or D in the ASIA Impairment Scale (AIS). 3. Must have a SCI level at T10 or higher as determined by ISNCSCI, with the region extending 6 cm above the tip of the …
Contacts

Jocelyne Bloch, Prof. Dr. MD

+41 79 556 29 51

jocelyne.bloch@chuv.ch

CONTACT